Market Place
Sourcing Support
Route 92 Medical Settles Patent Litigation with QApel Medical
06 May 2025 //
GLOBENEWSWIRE
Route 92 Medical Gets TGA Nod For Neurovascular Stroke Devices
27 Mar 2025 //
GLOBENEWSWIRE
Route 92 Medical Gains EU & MDSAP Certification For Stroke Portfolio
20 Nov 2024 //
GLOBENEWSWIRE
Route 92 Files Patent Infringement Suit Against Q`Apel Medical
07 Oct 2024 //
GLOBENEWSWIRE
Stroke devicemaker Route 92 Medical raises $50M to go global
23 Sep 2024 //
FIERCE BIOTECH
Route 92 Medical Announces Commercial Launch of FreeClimb 88 Catheter System
22 Jul 2024 //
GLOBENEWSWIRE
Route 92 Gets FDA 510(k) for FreeClimb 54 Reperfusion System
30 Apr 2024 //
GLOBENEWSWIRE
Route 92 Announces Completion of Enrollment in the SUMMIT MAX Clinical Trial
21 Feb 2024 //
GLOBENEWSWIRE
Route 92 Announces the 100th Patent for its Neurovascular Intervention Portfolio
08 Jan 2024 //
GLOBENEWSWIRE
Route 92 Medical Raises $31 Million in Oversubscribed Series F Equity Financing
16 Nov 2023 //
GLOBENEWSWIRE
Route 92 Announces Impressive Clinical Results for its Tenzing® Technology.
14 Nov 2023 //
GLOBENEWSWIRE
Route 92 Announces Appointment of Jonathan Kennedy as Chief Financial Officer
18 Sep 2023 //
GLOBENEWSWIRE
Route 92 Medical Announces Publication of a Retrospective Study in Journal
31 Jul 2023 //
GLOBENEWSWIRE
Route 92 Medical Appoints Chris Hartman as Chief Commercial Officer
10 Jul 2023 //
GLOBENEWSWIRE
Route 92 Medical Receives the First FDA Clearance for Stroke Treatment System
24 Apr 2023 //
GLOBENEWSWIRE
Route 92 Medical Begins Patient Enrollment in the SUMMIT MAX Pivotal Trial
08 Feb 2022 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.